BIIB34:BVMF
Biogen Inc BDR
R$186.01
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BIIB34...
Buksan
R$186.01
Mataas
R$186.01
Mababa
R$186.01
Mkt. cap
33.35B
Avg. na dami
7.00
Dami
1.00
Mataas nang 52-wk
R$191.00
Mababa nang 52-wk
R$128.69
Mga natitirang share
147.75M
Bilang ng mga empleyado
8K
Buksan
R$186.01
Mataas
R$186.01
Mababa
R$186.01
Mkt. cap
33.35B
Avg. na dami
7.00
Dami
1.00
Mataas nang 52-wk
R$191.00
Mababa nang 52-wk
R$128.69
Mga natitirang share
147.75M
Bilang ng mga empleyado
8K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com Nigeria
·
1 minuto ang nakalipas
JPMorgan gets bullish on Biogen ahead of 2027 catalysts By Investing.com
The Boston Globe
·
14 minuto ang nakalipas
Local life sciences scene ‘can’t just rest on our laurels,’ Biogen CEO warns
CNBC
·
16 minuto ang nakalipas
Stocks making the biggest moves premarket: Salesforce, First Solar, Biogen & more
Traders Union
·
56 minuto ang nakalipas
Biogen upgrade points to pipeline trial catalysts and share upside
Profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs.
The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Tungkol sa Biogen Inc BDR
CEOChris Viehbacher
Mga Empleyado7.5K
Itinatag1978
HeadquartersCambridge, Massachusetts, Estados Unidos
Sektor-
Websitebiogen.com